Publication Results

Generate Report

Add publications by marking their checkboxes, or

Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Pinsky PF,  Black A,  Daugherty SE,  Hoover R,  Parnes H,  Smith ZL,  Eggener S,  Andriole GL,  Berndt SI
Cancer 2019 Sep 1;125(17):2965-2974
Major Program(s) or Research Group(s): Early DetectionProstate and Urologic Cancer
PubMed ID: 31067347
PMC ID: PMC6690759 [available on September 01, 2020]

Overall mortality in men and women in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Pinsky PF,  Miller EA,  Zhu CS,  Prorok PC
J Med Screen 2019 Sep;26(3):127-134
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 30943843
PMC ID: not available

Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial.

Pinsky PF,  Miller E,  Prorok P,  Grubb R,  Crawford ED,  Andriole G
BJU Int 2019 May;123(5):854-860
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 30288918
PMC ID: PMC6450783 [available on May 01, 2020]

Lung Cancer Screening Benefits and Harms Stratified by Patient Risk: Information to Improve Patient Decision Aids.

Bellinger C,  Pinsky P,  Foley K,  Case D,  Dharod A,  Miller D
Ann Am Thorac Soc 2019 Apr;16(4):512-514
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 30620619
PMC ID: PMC6943875

Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma.

Siddharth S,  Muniraj N,  Saxena NK,  Sharma D
Cancers (Basel) 2019 Mar 30;11(4)
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 30934990
PMC ID: PMC6521104

Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.

Pierre-Victor D,  Pinsky PF
JAMA Intern Med 2019 Feb 1;179(2):196-203
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly Detection
PubMed ID: 30592477
PMC ID: PMC6439655

Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.

Miller EA,  Pinsky PF,  Pierre-Victor D
Cancer Causes Control 2019 Feb;30(2):215-216
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly Detection
PubMed ID: 30506128
PMC ID: not available

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.

Miller EA,  Pinsky PF,  Schoen RE,  Prorok PC,  Church TR
Lancet Gastroenterol Hepatol 2019 Feb;4(2):101-110
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30502933
PMC ID: PMC6335177

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.

Thomas A,  Pattanayak P,  Szabo E,  Pinsky P
Chest 2018 Dec;154(6):1284-1290
Major Program(s) or Research Group(s): Early DetectionLung and Upper Aerodigestive Cancer
PubMed ID: 30080997
PMC ID: PMC6335258

The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.

Miller EA,  Pinsky PF,  Pierre-Victor D
Cancer Causes Control 2018 Oct;29(10):907-914
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30094676
PMC ID: not available

Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.

Pinsky PF,  Loberg M,  Senore C,  Wooldrage K,  Atkin W,  Bretthauer M,  Cross AJ,  Hoff G,  Holme O,  Kalager M,  Segnan N,  Schoen RE
Gastroenterology 2018 Oct;155(4):1059-1068.e2
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29935150
PMC ID: not available

Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention.

Pinsky PF
JAMA 2018 Aug 14;320(6):600
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 30120468
PMC ID: not available

Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial.

Miller EA,  Pinsky PF,  Black A,  Andriole GL,  Pierre-Victor D
Prostate 2018 Aug;78(11):830-838
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29667217
PMC ID: not available

The IARC Perspective on Colorectal Cancer Screening.

Pinsky P,  Rabeneck L,  Lauby-Secretan B
N Engl J Med 2018 Jul 19;379(3):301-302
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 30021099
PMC ID: not available

Lung cancer screening with low-dose CT: a world-wide view.

Pinsky PF
Transl Lung Cancer Res 2018 Jun;7(3):234-242
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 30050762
PMC ID: PMC6037972

False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making.

Pinsky PF,  Bellinger CR,  Miller DP Jr
J Med Screen 2018 Jun;25(2):110-112
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28929865
PMC ID: not available

Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort.

Pinsky PF,  Miller E,  Heckman-Stoddard B,  Minasian L
Am J Obstet Gynecol 2018 Jun;218(6):606.e1-606.e9
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director
PubMed ID: 29630889
PMC ID: PMC5970073

Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.

Click B,  Pinsky PF,  Hickey T,  Doroudi M,  Schoen RE
JAMA 2018 May 15;319(19):2021-2031
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29800214
PMC ID: PMC6583246

Comment on "Systematic review and meta-analysis by Dube et al."

Pinsky PF
Am J Gastroenterol 2018 May;113(5):780-781
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 29453379
PMC ID: not available

Muscle-strengthening and aerobic activities and mortality among 3+ year cancer survivors in the U.S.

Tarasenko YN,  Linder DF,  Miller EA
Cancer Causes Control 2018 May;29(4-5):475-484
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 29511931
PMC ID: not available

Does the evidence support the implementation of lung cancer screening with low-dose computed tomography?

Pinsky PF
Expert Rev Respir Med 2018 Apr;12(4):257-260
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 29338501
PMC ID: not available

The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials.

de Koning HJ,  Gulati R,  Moss SM,  Hugosson J,  Pinsky PF,  Berg CD,  Auvinen A,  Andriole GL,  Roobol MJ,  Crawford ED,  Nelen V,  Kwiatkowski M,  Zappa M,  Luján M,  Villers A,  de Carvalho TM,  Feuer EJ,  Tsodikov A,  Mariotto AB,  Heijnsdijk EAM,  Etzioni R
Cancer 2018 Mar 15;124(6):1197-1206
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29211316
PMC ID: PMC5839977

Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.

Prorok PC,  Wright P,  Riley TR,  Kramer BS,  Berg CD,  Gohagan JK
Rev Recent Clin Trials 2018;13(4):257-273
Major Program(s) or Research Group(s): BiometryEarly Detection ;  Office of the Director
PubMed ID: 29629665
PMC ID: not available

Concomitant activation of ETS-like transcription factor-1 and Death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice.

Kuppusamy P,  Nagalingam A,  Muniraj N,  Saxena NK,  Sharma D
Sci Rep 2017 Dec 20;7(1):17943
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 29263422
PMC ID: PMC5738353

Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?

Doroudi M,  Schoen RE,  Pinsky PF
Cancer 2017 Dec 15;123(24):4815-4822
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 28976536
PMC ID: PMC5716922

The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.

Doroudi M,  Kramer BS,  Pinsky PF
J Med Screen 2017 Dec;24(4):220-222
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly Detection ;  Office of the Director
PubMed ID: 27903809
PMC ID: not available

The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.

Sonavane SK,  Pinsky P,  Watts J Jr,  Gierada DS,  Munden R,  Singh SP,  Nath H
Eur Radiol 2017 Dec;27(12):5113-5118
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28616728
PMC ID: not available

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival.

Temkin SM,  Miller EA,  Samimi G,  Berg CD,  Pinsky P,  Minasian L
Eur J Cancer 2017 Dec;87:182-188
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director
PubMed ID: 29156299
PMC ID: not available

Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.

Pinsky PF,  Gierada DS,  Nath PH,  Munden R
AJR Am J Roentgenol 2017 Nov;209(5):1009-1014
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28898131
PMC ID: not available

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Tsodikov A,  Gulati R,  Heijnsdijk EAM,  Pinsky PF,  Moss SM,  Qiu S,  de Carvalho TM,  Hugosson J,  Berg CD,  Auvinen A,  Andriole GL,  Roobol MJ,  Crawford ED,  Nelen V,  Kwiatkowski M,  Zappa M,  Luján M,  Villers A,  Feuer EJ,  de Koning HJ,  Mariotto AB,  Etzioni R
Ann Intern Med 2017 Oct 3;167(7):449-455
Major Program(s) or Research Group(s): Early DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 28869989
PMC ID: PMC5734053

Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.

Gierada DS,  Pinsky PF,  Duan F,  Garg K,  Hart EM,  Kazerooni EA,  Nath H,  Watts JR Jr,  Aberle DR
Eur Radiol 2017 Aug;27(8):3249-3256
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28050695
PMC ID: not available

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.

Skates SJ,  Greene MH,  Buys SS,  Mai PL,  Brown P,  Piedmonte M,  Rodriguez G,  Schorge JO,  Sherman M,  Daly MB,  Rutherford T,  Brewster WR,  O'Malley DM,  Partridge E,  Boggess J,  Drescher CW,  Isaacs C,  Berchuck A,  Domchek S,  Davidson SA,  Edwards R,  Elg SA,  Wakeley K,  Phillips KA,  Armstrong D,  Horowitz I,  Fabian CJ,  Walker J,  Sluss PM,  Welch W,  Minasian L,  Horick NK,  Kasten CH,  Nayfield S,  Alberts D,  Finkelstein DM,  Lu KH
Clin Cancer Res 2017 Jul 15;23(14):3628-3637
Major Program(s) or Research Group(s): Breast and Gynecologic CancerEarly Detection ;  Office of the Director
PubMed ID: 28143870
PMC ID: PMC5726402

Prostate Cancer Screening.

Pinsky PF,  Prorok PC,  Kramer BJ
N Engl J Med 2017 Jun 15;376(24):2402
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 28614680
PMC ID: not available

Incidental renal tumours on low-dose CT lung cancer screening exams.

Pinsky PF,  Dunn B,  Gierada D,  Nath PH,  Munden R,  Berland L,  Kramer BS
J Med Screen 2017 Jun;24(2):104-109
Major Program(s) or Research Group(s): BiometryEarly Detection ;  Office of the Director
PubMed ID: 28482765
PMC ID: not available

Data sharing in clinical trials: An experience with two large cancer screening trials.

Zhu CS,  Pinsky PF,  Moler JE,  Kukwa A,  Mabie J,  Rathmell JM,  Riley T,  Prorok PC,  Berg CD
PLoS Med 2017 May;14(5):e1002304
Major Program(s) or Research Group(s): BiometryEarly Detection ;  Office of the Director
PubMed ID: 28542201
PMC ID: PMC5441574

Flexible sigmoidoscopy screening: is once enough?

Pinsky PF
Lancet 2017 Apr 1;389(10076):1275-1277
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28236465
PMC ID: not available

Prostate Cancer Screening - A Perspective on the Current State of the Evidence.

Pinsky PF,  Prorok PC,  Kramer BS
N Engl J Med 2017 Mar 30;376(13):1285-1289
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 28355509
PMC ID: not available

Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.

Pinsky PF,  Prorok PC,  Yu K,  Kramer BS,  Black A,  Gohagan JK,  Crawford ED,  Grubb RL,  Andriole GL
Cancer 2017 Feb 15;123(4):592-599
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27911486
PMC ID: PMC5725951

Commentary on "Screening for lung cancer" by Sateia et al.

Pinsky PF
Semin Oncol 2017 Feb;44(1):83-84
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28395769
PMC ID: not available

Racial and Ethnic Differences in a Linkage with the National Death Index.

Miller EA,  McCarty FA,  Parker JD
Ethn Dis 2017 Spring;27(2):77-84
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 28439177
PMC ID: PMC5398181

Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort.

Pinsky PF,  Yu K,  Black A,  Huang WY,  Prorok PC
Cancer Epidemiol 2016 Dec;45:26-31
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 27687075
PMC ID: PMC5124516

The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.

Zhu CS,  Huang WY,  Pinsky PF,  Berg CD,  Sherman M,  Yu KJ,  Carrick DM,  Black A,  Hoover R,  Lenz P,  Williams C,  Hawkins L,  Chaloux M,  Yurgalevitch S,  Mathew S,  Miller A,  Olivo V,  Khan A,  Pretzel SM,  Multerer D,  Beckmann P,  Broski KG,  Freedman ND
Cancer Epidemiol Biomarkers Prev 2016 Dec;25(12):1635-1642
Major Program(s) or Research Group(s): Breast and Gynecologic CancerBiometryEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27635065
PMC ID: PMC5135604

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.

Marcus PM,  Pashayan N,  Church TR,  Doria-Rose VP,  Gould MK,  Hubbard RA,  Marrone M,  Miglioretti DL,  Pharoah PD,  Pinsky PF,  Rendle KA,  Robbins HA,  Roberts MC,  Rolland B,  Schiffman M,  Tiro JA,  Zauber AG,  Winn DM,  Khoury MJ
Cancer Epidemiol Biomarkers Prev 2016 Nov;25(11):1449-1455
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly Detection
PubMed ID: 27507769
PMC ID: PMC5165650

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.

Pinsky PF,  Yu K,  Kramer BS,  Black A,  Buys SS,  Partridge E,  Gohagan J,  Berg CD,  Prorok PC
Gynecol Oncol 2016 Nov;143(2):270-275
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 27615399
PMC ID: PMC5077651

Colorectal Cancer Screening.

Pinsky PF,  Doroudi M
JAMA 2016 Oct 25;316(16):1715
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 27784086
PMC ID: not available

More on Reevaluating PSA Testing Rates in the PLCO Trial.

Pinsky P,  Prorok P
N Engl J Med 2016 Oct 13;375(15):1500-1501
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 27732807
PMC ID: not available

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Patz EF Jr,  Greco E,  Gatsonis C,  Pinsky P,  Kramer BS,  Aberle DR
Lancet Oncol 2016 May;17(5):590-9
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director
PubMed ID: 27009070
PMC ID: PMC5094059

Definition of Specificity in a Screening Trial.

Pinsky PF
J Clin Oncol 2016 Jan 10;34(2):198
Major Program(s) or Research Group(s): Early Detection
PubMed ID: 26573070
PMC ID: not available

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Sampson JN,  Wheeler WA,  Yeager M,  Panagiotou O,  Wang Z,  Berndt SI,  Lan Q,  Abnet CC,  Amundadottir LT,  Figueroa JD,  Landi MT,  Mirabello L,  Savage SA,  Taylor PR,  De Vivo I,  McGlynn KA,  Purdue MP,  Rajaraman P,  Adami HO,  Ahlbom A,  Albanes D,  Amary MF,  An SJ,  Andersson U,  Andriole G Jr,  Andrulis IL,  Angelucci E,  Ansell SM,  Arici C,  Armstrong BK,  Arslan AA,  Austin MA,  Baris D,  Barkauskas DA,  Bassig BA,  Becker N,  Benavente Y,  Benhamou S,  Berg C,  Van Den Berg D,  Bernstein L,  Bertrand KA,  Birmann BM,  Black A,  Boeing H,  Boffetta P,  Boutron-Ruault MC,  Bracci PM,  Brinton L,  Brooks-Wilson AR,  Bueno-de-Mesquita HB,  Burdett L,  Buring J,  Butler MA,  Cai Q,  Cancel-Tassin G,  Canzian F,  Carrato A,  Carreon T,  Carta A,  Chan JK,  Chang ET,  Chang GC,  Chang IS,  Chang J,  Chang-Claude J,  Chen CJ,  Chen CY,  Chen C,  Chen CH,  Chen C,  Chen H,  Chen K,  Chen KY,  Chen KC,  Chen Y,  Chen YH,  Chen YS,  Chen YM,  Chien LH,  Chirlaque MD,  Choi JE,  Choi YY,  Chow WH,  Chung CC,  Clavel J,  Clavel-Chapelon F,  Cocco P,  Colt JS,  Comperat E,  Conde L,  Connors JM,  Conti D,  Cortessis VK,  Cotterchio M,  Cozen W,  Crouch S,  Crous-Bou M,  Cussenot O,  Davis FG,  Ding T,  Diver WR,  Dorronsoro M,  Dossus L,  Duell EJ,  Ennas MG,  Erickson RL,  Feychting M,  Flanagan AM,  Foretova L,  Fraumeni JF Jr,  Freedman ND,  Beane Freeman LE,  Fuchs C,  Gago-Dominguez M,  Gallinger S,  Gao YT,  Gapstur SM,  Garcia-Closas M,  García-Closas R,  Gascoyne RD,  Gastier-Foster J,  Gaudet MM,  Gaziano JM,  Giffen C,  Giles GG,  Giovannucci E,  Glimelius B,  Goggins M,  Gokgoz N,  Goldstein AM,  Gorlick R,  Gross M,  Grubb R 3rd,  Gu J,  Guan P,  Gunter M,  Guo H,  Habermann TM,  Haiman CA,  Halai D,  Hallmans G,  Hassan M,  Hattinger C,  He Q,  He X,  Helzlsouer K,  Henderson B,  Henriksson R,  Hjalgrim H,  Hoffman-Bolton J,  Hohensee C,  Holford TR,  Holly EA,  Hong YC,  Hoover RN,  Horn-Ross PL,  Hosain GM,  Hosgood HD 3rd,  Hsiao CF,  Hu N,  Hu W,  Hu Z,  Huang MS,  Huerta JM,  Hung JY,  Hutchinson A,  Inskip PD,  Jackson RD,  Jacobs EJ,  Jenab M,  Jeon HS,  Ji BT,  Jin G,  Jin L,  Johansen C,  Johnson A,  Jung YJ,  Kaaks R,  Kamineni A,  Kane E,  Kang CH,  Karagas MR,  Kelly RS,  Khaw KT,  Kim C,  Kim HN,  Kim JH,  Kim JS,  Kim YH,  Kim YT,  Kim YC,  Kitahara CM,  Klein AP,  Klein RJ,  Kogevinas M,  Kohno T,  Kolonel LN,  Kooperberg C,  Kricker A,  Krogh V,  Kunitoh H,  Kurtz RC,  Kweon SS,  LaCroix A,  Lawrence C,  Lecanda F,  Lee VH,  Li D,  Li H,  Li J,  Li YJ,  Li Y,  Liao LM,  Liebow M,  Lightfoot T,  Lim WY,  Lin CC,  Lin D,  Lindstrom S,  Linet MS,  Link BK,  Liu C,  Liu J,  Liu L,  Ljungberg B,  Lloreta J,  Di Lollo S,  Lu D,  Lund E,  Malats N,  Mannisto S,  Le Marchand L,  Marina N,  Masala G,  Mastrangelo G,  Matsuo K,  Maynadie M,  McKay J,  McKean-Cowdin R,  Melbye M,  Melin BS,  Michaud DS,  Mitsudomi T,  Monnereau A,  Montalvan R,  Moore LE,  Mortensen LM,  Nieters A,  North KE,  Novak AJ,  Oberg AL,  Offit K,  Oh IJ,  Olson SH,  Palli D,  Pao W,  Park IK,  Park JY,  Park KH,  Patiño-Garcia A,  Pavanello S,  Peeters PH,  Perng RP,  Peters U,  Petersen GM,  Picci P,  Pike MC,  Porru S,  Prescott J,  Prokunina-Olsson L,  Qian B,  Qiao YL,  Rais M,  Riboli E,  Riby J,  Risch HA,  Rizzato C,  Rodabough R,  Roman E,  Roupret M,  Ruder AM,  Sanjose Sd,  Scelo G,  Schned A,  Schumacher F,  Schwartz K,  Schwenn M,  Scotlandi K,  Seow A,  Serra C,  Serra M,  Sesso HD,  Setiawan VW,  Severi G,  Severson RK,  Shanafelt TD,  Shen H,  Shen W,  Shin MH,  Shiraishi K,  Shu XO,  Siddiq A,  Sierrasesúmaga L,  Sihoe AD,  Skibola CF,  Smith A,  Smith MT,  Southey MC,  Spinelli JJ,  Staines A,  Stampfer M,  Stern MC,  Stevens VL,  Stolzenberg-Solomon RS,  Su J,  Su WC,  Sund M,  Sung JS,  Sung SW,  Tan W,  Tang W,  Tardón A,  Thomas D,  Thompson CA,  Tinker LF,  Tirabosco R,  Tjønneland A,  Travis RC,  Trichopoulos D,  Tsai FY,  Tsai YH,  Tucker M,  Turner J,  Vajdic CM,  Vermeulen RC,  Villano DJ,  Vineis P,  Virtamo J,  Visvanathan K,  Wactawski-Wende J,  Wang C,  Wang CL,  Wang JC,  Wang J,  Wei F,  Weiderpass E,  Weiner GJ,  Weinstein S,  Wentzensen N,  White E,  Witzig TE,  Wolpin BM,  Wong MP,  Wu C,  Wu G,  Wu J,  Wu T,  Wu W,  Wu X,  Wu YL,  Wunder JS,  Xiang YB,  Xu J,  Xu P,  Yang PC,  Yang TY,  Ye Y,  Yin Z,  Yokota J,  Yoon HI,  Yu CJ,  Yu H,  Yu K,  Yuan JM,  Zelenetz A,  Zeleniuch-Jacquotte A,  Zhang XC,  Zhang Y,  Zhao X,  Zhao Z,  Zheng H,  Zheng T,  Zheng W,  Zhou B,  Zhu M,  Zucca M,  Boca SM,  Cerhan JR,  Ferri GM,  Hartge P,  Hsiung CA,  Magnani C,  Miligi L,  Morton LM,  Smedby KE,  Teras LR,  Vijai J,  Wang SS,  Brennan P,  Caporaso NE,  Hunter DJ,  Kraft P,  Rothman N,  Silverman DT,  Slager SL,  Chanock SJ,  Chatterjee N
J Natl Cancer Inst 2015 Dec;107(12):djv279
Major Program(s) or Research Group(s): Early DetectionNutritional ScienceProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 26464424
PMC ID: PMC4806328

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening.

Pinsky PF,  Kramer BS
J Natl Cancer Inst 2015 Nov;107(11)
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 26483244
PMC ID: PMC4849359